These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11363899)

  • 21. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP
    Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing opportunistic infections.
    Cheng B
    PI Perspect; 1995 May; (no 16):14-5. PubMed ID: 11362422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
    Schouten JT; Whittemore S
    STEP Perspect; 1996; 8(3):5-6. PubMed ID: 11364267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Opportunistic infections--prevention and treatment].
    Sidahora; 1995; ():42-7. PubMed ID: 11362439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of opportunistic infections in patients with HIV infection.
    Finkelstein DM; Williams PL; Molenberghs G; Feinberg J; Powderly WG; Kahn J; Dolin R; Cotton D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):38-45. PubMed ID: 8624759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevention and treatment of opportunistic infections].
    Nevot Falcó S; Bartralot Soler J
    Allergol Immunopathol (Madr); 1998; 26(3):144-50. PubMed ID: 9675398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AIDS related opportunistic infections, going but not gone.
    Samuel R; Bettiker RL; Suh B
    Arch Pharm Res; 2002 Jun; 25(3):215-28. PubMed ID: 12135090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunistic infections update.
    PI Perspect; 1996 Nov; (No 20):15-6. PubMed ID: 11363966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunistic infections update.
    Proj Inf Perspect; 1998 Apr; (24):17-9. PubMed ID: 11365715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current status in the prevention of Mycobacterium avium complex infections in patients with HIV infection].
    Doco-Lecompte T; Brel F; May T; Perronne C
    Ann Med Interne (Paris); 1997; 148(2):167-71. PubMed ID: 9238443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What's new in treatment?
    Collier AC
    J Clin Apher; 1993; 8(3):168-73; discussion 181-6. PubMed ID: 7507922
    [No Abstract]   [Full Text] [Related]  

  • 33. Medicine's arsenal in battling 'dominant dozen,' other AIDS-associated opportunistic infections.
    Cotton P
    JAMA; 1991 Sep; 266(11):1476-8, 1481. PubMed ID: 1880874
    [No Abstract]   [Full Text] [Related]  

  • 34. From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS.
    Laughon BE; Allaudeen HS; Becker JM; Current WL; Feinberg J; Frenkel JK; Hafner R; Hughes WT; Laughlin CA; Meyers JD
    J Infect Dis; 1991 Aug; 164(2):244-51. PubMed ID: 1649870
    [No Abstract]   [Full Text] [Related]  

  • 35. Macrolides, azalides, and streptogrammins.
    Prescott LM
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):35-7. PubMed ID: 11363516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opportunistic infection highlights from the 35th ICAAC.
    Torres G
    GMHC Treat Issues; 1995 Oct; 9(10):8, 10-2. PubMed ID: 11362919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for AIDS and associated infections.
    Med Lett Drugs Ther; 1995 Oct; 37(959):87-94. PubMed ID: 7565297
    [No Abstract]   [Full Text] [Related]  

  • 38. Ancillary benefits of Mycobacterium avium-intracellulare complex prophylaxis with clarithromycin in HIV-infected patients.
    Jablonowski H; Fätkenheuer G; Youle M; Newell T; Lines S; Craft JC
    Drugs; 1997; 54 Suppl 2():16-22; discussion 28-9. PubMed ID: 9358196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifabutin levels may increase with fluconazole during MAC treatment.
    AIDS Patient Care STDS; 1996 Oct; 10(5):310. PubMed ID: 11361528
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.